(Q40114134)

17 September 2017

Expression of the p210BCR-ABL oncoprotein drives centrosomal hypertrophy and clonal evolution in human U937 cells (English)

1 reference

17 September 2017

7

1 reference

17 September 2017

Giehl M

1

1 reference

17 September 2017

Fabarius A

2

1 reference

17 September 2017

Frank O

3

1 reference

17 September 2017

Erben P

4

1 reference

17 September 2017

Zheng C

5

1 reference

17 September 2017

Hafner M

6

1 reference

17 September 2017

Hehlmann R

8

1 reference

17 September 2017

Seifarth W

9

1 reference

17 September 2017

language of work or name

1 reference

28 June 2007

1 reference

17 September 2017

1 reference

17 September 2017

21

1 reference

17 September 2017

9

1 reference

17 September 2017

1971-1976

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404834

17 September 2017

0 references

cites work

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

The biology of CML blast crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Detection and quantification of residual disease in chronic myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Detection in primary chronic myeloid leukaemia cells of p210BCR-ABL1 in complexes with adaptor proteins CBL, CRKL, and GRB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Rules for making human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Centrosome composition and microtubule anchoring mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Proteomic characterization of the human centrosome by protein correlation profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Structure meets function--centrosomes, genome maintenance and the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Centrosomes in cellular regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Mitotic kinases as regulators of cell division and its checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Checking out the centrosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Centrosome aberrations in chronic myeloid leukemia correlate with stage of disease and chromosomal instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Induction of centrosome and chromosome aberrations by imatinib in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Establishment and phenotypic characterization of human U937 cells with inducible P210 BCR/ABL expression reveals upregulation of CEACAM1 (CD66a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Molecular monitoring of chronic myelogenous leukemia: identification of the most suitable internal control gene for real-time quantification of BCR-ABL transcripts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Clonal evolution in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

The BRCA1 E3 ubiquitin ligase controls centrosome dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Centrosome function in normal and tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Constitutive association of BRCA1 and c-Abl and its ATM-dependent disruption after irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Complex chromosomal rearrangements in patients with chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

7 January 2021

Cell biology. Do centrosome abnormalities lead to cancer?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

7 January 2021

Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

7 January 2021

Dose-dependent effects of Bcr-Abl in cell line models of different stages of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

7 January 2021

Random aneuploidy in CML patients at diagnosis and under imatinib treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

7 January 2021

Inhibition of BRCA1 in breast cell lines causes the centrosome duplication cycle to be disconnected from the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404834

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404834

1 reference

Dimensions Publication ID

17 September 2017

0 references

1 reference